Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia.

Venue / Journal

Blood

Date

Thu, 03/01/2001 - 12:00

Additional Journal Information

97(5):1404-12

Authors

Peters DG, Hoover RR, Gerlach MJ, Koh EY, Zhang H, Choe K, Kirschmeier P, Bishop WR, Daley GQ.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/11222387